Rockwell Medical (NASDAQ:RMTI) Posts Quarterly Earnings Results

Rockwell Medical (NASDAQ:RMTI) posted its quarterly earnings results on Tuesday. The company reported ($0.02) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.03, Zacks reports. Rockwell Medical had a negative net margin of 9.72% and a negative return on equity of 28.29%. The business had revenue of $22.68 million for the quarter, compared to analysts’ expectations of $21.18 million. During the same period in the prior year, the company posted ($0.10) EPS. Rockwell Medical updated its FY 2024 guidance to EPS.

Rockwell Medical Trading Down 2.3 %

Shares of RMTI stock opened at $1.70 on Friday. The stock has a market cap of $51.54 million, a P/E ratio of -4.83 and a beta of 1.21. The company has a quick ratio of 1.38, a current ratio of 1.79 and a debt-to-equity ratio of 0.47. Rockwell Medical has a fifty-two week low of $1.16 and a fifty-two week high of $6.24. The business has a fifty day simple moving average of $1.57 and a 200-day simple moving average of $1.61.

Analysts Set New Price Targets

Separately, HC Wainwright restated a “buy” rating and set a $9.00 target price on shares of Rockwell Medical in a research report on Thursday.

Rockwell Medical Company Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.